論文 - 詳細
| RRC ID | 58105 |
|---|---|
| 著者 | Mulazzani M, Huber M, Borchard S, Langer S, Angele B, Schuh E, Meinl E, Dreyling M, Birnbaum T, Straube A, Koedel U, von Baumgarten L. |
| タイトル | APRIL and BAFF: novel biomarkers for central nervous system lymphoma. |
| ジャーナル | J Hematol Oncol |
| Abstract |
BACKGROUND:Early diagnosis of CNS lymphoma (CNSL) is essential for successful therapy of this rapidly progressing brain tumor. However, in patients presenting with focal brain lesions, fast and reliable diagnosis of PCNSL remains a challenge. A proliferation-inducing ligand (APRIL) and B cell activating factor (BAFF) are important factors in the pathophysiology, diagnosis, and prognosis of systemic B cell malignancies. However, their utility as biomarkers for the diagnosis of CNSL and their effects on CNSL cells remain unclear. METHODS:In this prospective study, we analyzed the levels of APRIL and BAFF in the cerebrospinal fluid (CSF) of 116 patients with suspected focal brain lesions, including 53 CNSL patients. Additionally, we serially measured their levels during chemotherapy and relapse. Furthermore, we analyzed the effect of APRIL and BAFF on two B cell lymphoma cell lines using proliferation, viability, and chemotaxis assays. RESULTS:CSF levels of APRIL and BAFF reliably differentiated CNSL from other focal brain lesions (including primary and metastatic brain tumors, autoimmune-inflammatory lesions, and neuroinfectious lesions) with a specificity of 93.7% (APRIL, BAFF) and a sensitivity of 62.3% (APRIL) and 47.1% (BAFF). Serial CSF analysis of CNSL patients during chemotherapy and relapse demonstrates a close correlation of APRIL CSF levels and the course of this disease. In vitro, APRIL and BAFF showed anti-apoptotic effects during MTX treatment and mediated chemotaxis of malignant B cells. CONCLUSION:This study extends the spectrum of valuable diagnostic biomarkers in CNSL. In patients with focal brain lesions, measurement of APRIL in CSF could help accelerating the diagnosis of CNSL. Moreover, our results highlight an important role of APRIL and BAFF in the pathophysiology of CNSL. |
| 巻・号 | 12(1) |
| ページ | 102 |
| 公開日 | 2019-10-15 |
| DOI | 10.1186/s13045-019-0796-4 |
| PII | 10.1186/s13045-019-0796-4 |
| PMID | 31615554 |
| PMC | PMC6792247 |
| MeSH | B-Cell Activating Factor / genetics B-Cell Activating Factor / metabolism* Biomarkers, Tumor / blood* Central Nervous System Neoplasms / metabolism* Chemotaxis Gene Expression Regulation, Neoplastic Humans Lymphoma / metabolism* Prospective Studies Tumor Necrosis Factor Ligand Superfamily Member 13 / genetics Tumor Necrosis Factor Ligand Superfamily Member 13 / metabolism* |
| IF | 11.059 |
| 引用数 | 3 |
| リソース情報 | |
| ヒト・動物細胞 | HKBML(RCB0820) |